Acute Lymphoblastic Leukemia
📧 Sign up to get email alerts when something new happens for Acute Lymphoblastic Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-04-25Clinical Trial Update: Treatment of Acute Lymphoblastic Leukemia in Children [Phase 3]
Phase 3 clinical trial update for treatment of acute lymphoblastic leukemia in children; the trial status is completed.
-
CLINICAL_TRIALS trial_result · 2013-04-17Clinical Trial Update: Endothelial Function, Arterial Stiffness and Components
This clinical trial update reports on a completed study evaluating endothelial function and arterial stiffness in patients with Acute Lympho…
-
CLINICAL_TRIALS trial_result · 2013-04-09Clinical Trial Update: Deferoxamine for Iron Overload Before Allogeneic Stem Cell Transplantation [NA]
This clinical trial evaluated deferoxamine to manage iron overload before allogeneic stem cell transplantation in patients with acute myeloi…
-
CLINICAL_TRIALS trial_result · 2013-04-02Clinical Trial Update: Flavopiridol and Vorinostat in Treating Patients With Relapsed or Refractory Acute Leukemia or Chronic Myelogenous Leukemia or Refractory Anemia [Phase 1]
Phase 1 trial evaluating flavopiridol and vorinostat in relapsed or refractory acute leukemias and related myeloid disorders has completed e…
-
CLINICAL_TRIALS trial_result · 2013-03-26Clinical Trial Update: Imatinib Mesylate and Combination Chemotherapy With or Without a Donor Stem Cell Transplant in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia [Phase 2]
Phase 2 trial updating the use of Imatinib Mesylate with combination chemotherapy, with or without donor stem cell transplant, in newly diag…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-03-26Clinical Trial Update: Study for Safety and Efficacy Evaluation of Imatinib Mesylate in Children With Acute Lymphoblastic Leukemia (ALL) Philadelphia Chromosome-positive (Ph+) [Phase 2]
Phase 2 trial of imatinib mesylate in children with Philadelphia chromosome-positive acute lymphoblastic leukemia has been suspended.
-
CLINICAL_TRIALS trial_result · 2013-03-14Clinical Trial Update: Methotrexate or Pentostatin for Graft-versus-host Disease Prophylaxis in Risk-adapted Allogeneic Bone Marrow Transplantation for Hematologic Malignancies [Phase 3]
Phase 3 study evaluating methotrexate or pentostatin for graft-versus-host disease prophylaxis in risk-adapted allogeneic bone marrow transp…
-
CLINICAL_TRIALS trial_result · 2013-03-07Clinical Trial Update: Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia, Osteosarcoma, or Non-Hodgkin's Lymphoma [Phase 2]
This Phase 2 trial update reports the outcomes of a combination chemotherapy regimen in children with acute lymphoblastic leukemia, osteosar…
-
CLINICAL_TRIALS trial_result · 2013-03-04Clinical Trial Update: Clofarabine and Cyclophosphamide Combination in Acute Lymphoblastic Leukemia Patients [Phase 1, Phase 2]
A Phase 1/Phase 2 clinical trial evaluated the combination of clofarabine and cyclophosphamide in patients with acute lymphoblastic leukemia…
-
CLINICAL_TRIALS trial_result · 2013-02-28Clinical Trial Update: Observational Study of Iron Overload in Stem Cell Transplantation
This clinical trial update notes the completion of an observational study on iron overload in stem cell transplantation involving patients w…
-
CLINICAL_TRIALS trial_result · 2013-02-27Clinical Trial Update: Comparative Efficacy and Safety of Two Asparaginase Preparations in Children With Previously Untreated Acute Lymphoblastic Leukaemia [Phase 3]
Phase 3 trial comparing two asparaginase preparations in children with previously untreated acute lymphoblastic leukemia to assess efficacy …
-
CLINICAL_TRIALS trial_result · 2013-02-13Clinical Trial Update: Stem Cell Transplantation for Hematological Malignancies [Phase 2, Phase 3]
This clinical trial update reports termination of a Phase 2/Phase 3 study evaluating stem cell transplantation for hematologic malignancies.…
-
CLINICAL_TRIALS trial_result · 2013-02-12Clinical Trial Update: A Phase II Open-Label Study of High-Dose Cytarabine and Clofarabine in Adult Patients With Refractory or Relapsed Acute Myelogenous Leukemia or Refractory or Relapsed Acute Lymphoblastic Leukemia [Phase 2]
Phase II open-label study of high-dose cytarabine combined with clofarabine in adults with refractory or relapsed acute myeloid leukemia or …
-
CLINICAL_TRIALS trial_result · 2013-02-08Clinical Trial Update: XK469R in Treating Patients With Refractory Hematologic Cancer [Phase 1]
Phase 1 trial update reporting initial safety and tolerability findings for XK469R in patients with refractory hematologic cancers.
-
CLINICAL_TRIALS trial_result · 2013-02-08Clinical Trial Update: 6-Hydroxymethylacylfulvene in Treating Patients With Refractory Myelodysplastic Syndrome, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Blastic Phase Chronic Myelogenous Leukemia [Phase 1]
NCI-sponsored Phase 1 clinical trial update of 6-Hydroxymethylacylfulvene (Irofulven) in patients with refractory acute myeloid leukemia, ac…
-
CLINICAL_TRIALS trial_result · 2013-02-07Clinical Trial Update: Retrospective Evaluation of the Clinical Results Obtained in Patients With Acute Lymphoblastic Leukemia Treated at the San Giovanni Battista Hospital.
This report provides retrospective clinical results from patients with acute lymphoblastic leukemia treated at San Giovanni Battista Hospita…
-
FDA approval · 2013-02-05FDA Approved: METHOTREXATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved Hikma Pharmaceuticals USA's supplemental application for methotrexate, enabling the marketing of a generic methotrexate product…
-
CLINICAL_TRIALS trial_result · 2013-02-05Clinical Trial Update: 506U78 in Treating Patients With Refractory or Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma [Phase 2]
Phase 2 clinical trial update for 506U78 in patients with refractory or relapsed acute lymphoblastic leukemia or lymphoblastic lymphoma (NCI…
-
CLINICAL_TRIALS trial_result · 2013-02-05Clinical Trial Update: Dasatinib in Treating Young Patients With Recurrent or Refractory Solid Tumors or Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia or Chronic Myelogenous Leukemia That Did Not Respond to Imatinib Mesylate [Phase 1]
Phase 1 clinical trial update of dasatinib in pediatric patients with Philadelphia chromosome–positive leukemia or recurrent/refractory soli…
-
FDA approval · 2013-02-04FDA Approved: DOXORUBICIN HYDROCHLORIDE — Original Application (BluePoint Laboratories)
FDA approved a generic doxorubicin hydrochloride product under Original Application for BluePoint Laboratories (ANDA 203263). This marks app…
-
CLINICAL_TRIALS trial_result · 2013-02-04Clinical Trial Update: ALL-REZ BFM 2002: Multi-Center Study for Children With Relapsed Acute Lymphoblastic Leukemia [Phase 4]
Phase 4 multi-center trial ALL-REZ BFM 2002 for children with relapsed acute lymphoblastic leukemia has completed enrollment and status is c…
-
CLINICAL_TRIALS trial_result · 2013-02-01Clinical Trial Update: Radiation Therapy and Chemotherapy in Treating Children With CNS Relapse From Acute Lymphoblastic Leukemia [Phase 2]
A Phase 2 clinical trial evaluated radiation therapy combined with chemotherapy for children with CNS relapse of acute lymphoblastic leukemi…
-
CLINICAL_TRIALS trial_result · 2013-02-01Clinical Trial Update: Augmerosen Plus Fludarabine and Cytarabine in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia [Phase 1]
Phase 1 study of augmerosen with fludarabine and cytarabine in patients with refractory or relapsed acute myeloid leukemia or acute lymphobl…
-
CLINICAL_TRIALS trial_result · 2013-01-31Clinical Trial Update: Vaccine Therapy in Preventing Flu in Children With Acute Lymphoblastic Leukemia [NA]
A completed clinical trial evaluated a vaccine therapy to prevent influenza in children with acute lymphoblastic leukemia.
-
FDA approval · 2013-01-25FDA Approved: GLEEVEC — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for GLEEVEC (imatinib mesylate) submitted by Novartis, reflecting changes to the product labeling.